Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)
Operator of a novel cultivated-protein production process designed to create animal-cell-derived meat without conventional livestock. SymphoRNA is based in Cambridge, United Kingdom and was founded in 2017. Its last known valuation is $98.4 million. It has raised $49.2 million.
Last price · $/share
—
Implied valuation
$98.4M
Total raised
$49.2M
Last round
—
Cap table — not yet on record
SymphoRNA's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SymphoRNA with a free account
·The complete investor list: 22 names
·Watch SymphoRNA: the Monday email on marks, rounds and moves
